Gene changes in blood cells linked to higher cancer risk
Original title: Causal association between clonal hematopoiesis indeterminate potential and cancer: a Mendelian randomization study.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This looked at gene and health records from people. It is not a treatment being tested.
The short version
A common gene change in blood cells was tied to a higher risk of several cancers, including brain cancer.
What was studied. Researchers studied a blood condition called CHIP. It happens when blood stem cells pick up gene changes and grow into many copies. The team used genetic data from large health studies to compare CHIP with 18 types of cancer, covering 612,576 cancer cases.
What they found. People whose genes pointed to CHIP had a higher risk of several cancers. These included brain cancer, thyroid cancer, lung cancer, kidney cancer, basal cell carcinoma, and melanoma. Extra checks by the researchers gave the same answer. The size of the link changed depending on the exact type of cancer.
What this means, and what it doesn't
What it could mean: CHIP may be one thing that pushes cancer risk up, including brain cancer. The authors say checking people for CHIP might help catch cancer early. If a doctor has told you that you have CHIP, you can ask what it means for you.
What it doesn't mean: This is not a treatment. No drug was tested here. This kind of study looks at genes and risk across huge groups of people. It cannot say that CHIP caused any one person's brain tumor. Most people with CHIP will not get brain cancer. Nothing here changes the care you get today, and it is not a cure.
Source: PubMed, July 27, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.